Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) and Seer (NASDAQ:SEER – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, earnings, dividends and analyst recommendations.
Insider and Institutional Ownership
61.0% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 76.2% of Seer shares are held by institutional investors. 38.0% of Rapid Micro Biosystems shares are held by company insiders. Comparatively, 18.0% of Seer shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Get
Rapid Micro Biosystems alerts:
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for Rapid Micro Biosystems and Seer, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
| Rapid Micro Biosystems | 0 | 2 | 0 | 0 | 2.00 |
| Seer | 1 | 2 | 0 | 0 | 1.67 |
Rapid Micro Biosystems currently has a consensus target price of $10.00, indicating a potential upside of 629.93%. Seer has a consensus target price of $9.83, indicating a potential upside of 95.11%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, research analysts plainly believe Rapid Micro Biosystems is more favorable than Seer.
Profitability
This table compares Rapid Micro Biosystems and Seer's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
| Rapid Micro Biosystems | -328.18% | -29.41% | -26.52% |
| Seer | -646.27% | -18.80% | -17.32% |
Volatility & Risk
Rapid Micro Biosystems has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Comparatively, Seer has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500.
Earnings and Valuation
This table compares Rapid Micro Biosystems and Seer's gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
| Rapid Micro Biosystems | $23.23 million | 2.48 | -$73.52 million | ($1.39) | -0.99 |
| Seer | $6.62 million | 47.69 | -$71.17 million | ($1.45) | -3.48 |
Seer has lower revenue, but higher earnings than Rapid Micro Biosystems. Seer is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.
Summary
Rapid Micro Biosystems beats Seer on 7 of the 13 factors compared between the two stocks.
About Rapid Micro Biosystems
(Get Rating)
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
About Seer
(Get Rating)
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
